Neratinib (Nerlynx)

neratinib · Puma Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Neratinib (Nerlynx), covering 2012-05-14 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment [Phase 1, Phase 2]

See pricing